Delivery Order SPE2DR25D1017-SPE2DR26F9BFW
- Not listed
- The Defense Logistics Agency awarded a $5,607.96 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for supply of Miebo 100% eye drop in 3ml quantities. This is a firm fixed-price contract with an ultimate completion date of December 12, 2025, and represents a child delivery order under AmerisourceBergen's broader contract vehicle with DLA. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will be conducted at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,655.19 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop medication in 3ML units. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $5,322.00 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on September 3, 2025, with completion by September 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,654.93 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3mL) on December 9, 2025, with a completion date of December 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical transaction within the broader federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,030.93 of Miebo 100% eye drops (3mL) on December 8, 2025, with completion scheduled for December 9, 2025. This non-competitive delivery order represents a firm fixed price transaction executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,748.98 on November 25, 2025, for the supply of Miebo 100% eye drops (3ml). The Defense Logistics Agency (DLA) issued this competitively awarded, firm fixed-price delivery order, which is scheduled for completion by November 26, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,275.54 on December 4, 2025, for the supply of Miebo 100% eye drops (3ml). This is a firm fixed price, competitively awarded contract with a completion date of December 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $7,203.58 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for MIEBO 100% eye drops (3ML). This is a firm fixed-price, competitively awarded contract with a completion date of July 14, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with the agency. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against...
- The Defense Logistics Agency awarded a delivery order valued at $4,217.58 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on December 10, 2025, with completion targeted for December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at approximately $15.8K to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of MIEBO 100% eye drops (3 mL). This competitively awarded, firm fixed-price contract is scheduled for completion by November 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BFWDelivery Order
The Defense Logistics Agency awarded a $5,859.32 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Miebo 100% eye drop in 3ML units. This firm fixed price delivery order, with an ultimate completion date of December 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is non-competitive and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999.99 billion IDC with DLA Troop Support Medical (SPE2DX) running through December 2026, which serves as the overarching contract vehicle for this delivery order. This prime contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability in federal medical procurement, combined with its extensive portfolio of specialty medications and generic drugs, positions it as a critical vendor within the federal pharmaceutical supply chain for defense healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 12/10/25 |